CDH3 and neoplasm: The P-cadherin IHC analysis of both the tumor and normal tissue specimens was conducted in a subset of patients (n= 18) and confirmed the presence of P-cadherin in CRC tumor tissue and its absence in adjacent normal tissue (Figure-3).